Article info

Original research
Safety and efficacy of AMG 820, an anti-colony-stimulating factor 1 receptor antibody, in combination with pembrolizumab in adults with advanced solid tumors

Authors

  1. Correspondence to Dr Kyriakos P Papadopoulos; kyri.papadopoulos{at}startsa.com
View Full Text

Citation

Razak AR, Cleary JM, Moreno V, et al
Safety and efficacy of AMG 820, an anti-colony-stimulating factor 1 receptor antibody, in combination with pembrolizumab in adults with advanced solid tumors

Publication history

  • Accepted June 30, 2020
  • First published October 12, 2020.
Online issue publication 
October 12, 2020
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.